(0.31%) 5 115.86 points
(0.32%) 38 360 points
(0.34%) 15 982 points
(-0.94%) $83.06
(5.51%) $2.03
(0.36%) $2 355.60
(0.42%) $27.65
(4.02%) $959.20
(-0.24%) $0.932
(-0.38%) $10.98
(-0.55%) $0.796
(1.69%) $93.43
@ $43.60
発行日: 15 2月 2024 @ 05:55
リターン: -32.73%
前回のシグナル: 2月 15 - 02:37
前回のシグナル:
リターン: 0.58 %
Live Chart Being Loaded With Signals
Integra LifeSciences Holdings Corporation develops, manufactures, and markets surgical implants and medical instruments for use in neurosurgery, extremity reconstruction, and general surgery...
Stats | |
---|---|
本日の出来高 | 182 267 |
平均出来高 | 770 438 |
時価総額 | 2.29B |
EPS | $0 ( 2024-04-25 ) |
次の収益日 | ( $0.550 ) 2024-05-06 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | 34.92 |
ATR14 | $0.0370 (0.13%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-03-11 | De Witte Jan | Buy | 41 414 | Restricted Stock Units |
2024-03-11 | De Witte Jan | Sell | 205 | Restricted Stock Units |
2024-03-11 | De Witte Jan | Buy | 95 664 | Non- Qualified Stock Option (right to buy) |
2024-03-11 | De Witte Jan | Buy | 205 | Common Stock |
2024-03-11 | De Witte Jan | Sell | 205 | Common Stock |
INSIDER POWER |
---|
80.45 |
Last 97 transactions |
Buy: 599 911 | Sell: 62 631 |
ボリューム 相関
Integra Lifesciences 相関
10 最も負の相関 | |
---|---|
PLMR | -0.914 |
FTOC | -0.913 |
FTOCU | -0.913 |
FEYE | -0.9 |
HOLUU | -0.894 |
AYLA | -0.891 |
NRBO | -0.887 |
IMRX | -0.875 |
HHGCU | -0.874 |
TFFP | -0.872 |
知っていましたか?
相関は、2つの変数間の関係を説明する統計的指標です。相関係数は-1から1までの値を取り、-1は完全な負の相関(1つの変数が増加すると、もう一方は減少する)、1は完全な正の相関(1つの変数が増加すると、もう一方も増加する)、0は相関がないことを示します(変数間に関係がない)。
相関は、株式だけでなく、どの2つの変数間の関係にも適用できます。これは、金融、経済学、心理学などの分野で一般的に使用されています。
Integra Lifesciences 相関 - 通貨/商品
Integra Lifesciences 財務諸表
Annual | 2023 |
収益: | $1.54B |
総利益: | $888.39M (57.63 %) |
EPS: | $0.850 |
FY | 2023 |
収益: | $1.54B |
総利益: | $888.39M (57.63 %) |
EPS: | $0.850 |
FY | 2022 |
収益: | $1.56B |
総利益: | $970.31M (62.29 %) |
EPS: | $2.18 |
FY | 2021 |
収益: | $1.54B |
総利益: | $944.64M (61.24 %) |
EPS: | $1.996 |
Financial Reports:
No articles found.
Integra Lifesciences
Integra LifeSciences Holdings Corporation develops, manufactures, and markets surgical implants and medical instruments for use in neurosurgery, extremity reconstruction, and general surgery. It operates in two segments, Codman Specialty Surgical and Tissue Technologies. The company offers neurosurgery and neuro critical care products, including tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, intracranial monitoring equipment, and cranial stabilization equipment; and surgical headlamps and instrumentation, as well as asset management software and support, and after-market services. It also sells approximately 40,000 instrument patterns, and surgical and lighting products to hospitals and surgery centers, as well as dental, podiatry, and veterinary offices. In addition, the company provides regenerative technology products for the treatment of acute and chronic wounds; and surgical tissue repair products for hernia repair, peripheral nerve repair and protection, and tendon repair. Further, it offers skin and wound repair, plastics and surgical reconstruction products, bone grafts, and nerve and tendon repair products. The company offers its products directly through various sales forces and other distribution channels to the hospitals, integrated health networks, group purchasing organizations, clinicians, surgery centers, and health care providers in the United States, Europe, Asia Pacific, and internationally. Integra LifeSciences Holdings Corporation was incorporated in 1989 and is headquartered in Princeton, New Jersey.
について ライブシグナル
このページで提示されるライブシグナルは、NA を買う時や売る時を判断するのに役立ちます。シグナルには1分以上の遅延があります。市場シグナルには誤りやミスの可能性があるため、ライブ取引シグナルは決定的ではなく、getagraph.comはこれらのシグナルに基づく任意の行動について責任を負いません。詳細については、利用規約で説明されているように、技術分析指標に基づいています。